Medicare GLP‑1 Bridge confirms coverage of Foundayo, Wegovy, Zepbound KwikPen
New July 1, 2026 Medicare guidance confirms Medicare GLP‑1 Bridge covers Foundayo, all Wegovy options, and only Zepbound KwikPen for weight‑loss under $50/month.
- By
- Ian Gauntt, RN, BSN
- Published
- Read time
- 3 min
Key Takeaways
- Medicare GLP‑1 Bridge covers Foundayo tablets, all Wegovy forms, and only Zepbound KwikPen starting July 1, 2026.
- Eligible seniors with Part D pay $50/month for these weight‑loss GLP‑1s, outside Part D cost‑sharing.
- Single‑dose Zepbound vials or pens remain excluded from coverage.
- Providers must submit prior authorization under Bridge using correct product form and indication.
- Program runs from July 1, 2026 to December 31, 2027 with central CMS processing.
What does Medicare GLP‑1 Bridge cover starting July 1, 2026?
Medicare GLP‑1 Bridge covers Foundayo tablets. It covers all formulations of Wegovy—injection or pill. It includes only the KwikPen formulation of Zepbound; single‑dose pens or vials don't qualify (cms.gov). Beneficiaries pay $50 per month, outside of Part D cost‑sharing (medicare.gov).
Who qualifies and what do providers need to do?
Seniors need Medicare Part D through a standalone PDP or an MA‑PD plan. They must meet clinical criteria at therapy initiation—typically BMI thresholds or related conditions (cms.gov). Providers must send prescriptions with the note "SEND TO MEDICARE GLP‑1 BRIDGE FOR WEIGHT MANAGEMENT" and route prior authorization to CMS's central processor (cms.gov).
How long does the program run and what's next?
The Medicare GLP‑1 Bridge runs from July 1, 2026 through December 31, 2027 (cms.gov). CMS will collect data before BALANCE or broader coverage models may follow. The fixed $50 copay sits outside standard Part D payment flow to simplify administration (cms.gov).
FAQ
What is the Medicare GLP‑1 Bridge?
Medicare GLP‑1 Bridge is a short‑term demonstration that lets eligible Medicare Part D beneficiaries access certain GLP‑1 weight‑loss drugs for $50 a month outside normal Part D coverage.
Which GLP‑1 drugs does the Medicare GLP‑1 Bridge cover?
It covers Foundayo tablets, all Wegovy formulations (injection and oral), and only the Zepbound KwikPen. Single‑dose Zepbound pens or vials aren't included.
How much do seniors pay under Medicare GLP‑1 Bridge?
Seniors pay a flat $50 per month for covered GLP‑1 weight‑loss drugs through the Medicare GLP‑1 Bridge; this cost doesn't count toward deductibles or out‑of‑pocket limits.
Do providers need to meet clinical criteria to prescribe under the Medicare GLP‑1 Bridge?
Yes. Providers must certify the patient met Medicare's GLP‑1 Bridge clinical criteria—typically BMI thresholds or comorbidities—at therapy start, even if therapy began before July 1, 2026.
When does the Medicare GLP‑1 Bridge end?
The program runs from July 1, 2026 through December 31, 2027. CMS may extend or replace it with models like BALANCE afterward.
Not medical advice. GLP‑1 medications are prescription drugs and fasting is not right for everyone—talk to a licensed healthcare provider before starting, stopping, or changing any treatment or eating pattern.
Sources
Where this comes from
This article is educational, not medical advice. GLP-1 therapy and fasting decisions belong in a conversation with a clinician who knows your history.
Keep reading
Related articles
Fasting
Fasting Side Effects: What Research Shows
Learn what peer-reviewed studies say about fasting side effects on iron levels, immune cells, testosterone, and more. Not medical advice—talk to your doctor.
Fasting
Orforglipron Maintains Weight Loss After Injectables
ATTAIN‑MAINTAIN shows patients switching to the oral GLP‑1 orforglipron preserve about 75–79% of prior injectable weight loss over 52 weeks.
Fasting
Foundayo Delivers up to 13% Weight Loss in Older Adults
New ATTAIN‑1/2 analysis shows oral GLP‑1 pill Foundayo helps adults 65+ lose up to 13% body weight at 72 weeks. Medicare covers Foundayo starting July 1 with $50 copay.
The Slow Letter
Careful, source-checked notes on GLP-1s and fasting — no hype, no fear.
One measured email when there's something worth saying. Unsubscribe any time.